LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein.
Chen KL, Huang SW, Yao JJ, He SW, Gong S, Tan XR, Liang YL, Li JY, Huang SY, Li YQ, Zhao Y, Qiao H, Xu S, Zang S, Ma J, Liu N.
Chen KL, et al. Among authors: li jy, li yq.
Drug Resist Updat. 2024 Sep;76:101111. doi: 10.1016/j.drup.2024.101111. Epub 2024 Jun 14.
Drug Resist Updat. 2024.
PMID: 38908233